Precision BioSciences, Inc.
DTIL
$6.86
$0.091.33%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 10.84M | 34.20M | 13.00K | 18.00K | 29.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.84M | 34.20M | 13.00K | 18.00K | 29.00K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 10.84M | 34.20M | 13.00K | 18.00K | 29.00K |
| SG&A Expenses | 6.80M | 7.23M | 8.01M | 9.93M | 8.55M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 19.91M | 21.70M | 20.68M | 21.90M | 22.14M |
| Operating Income | -9.08M | 12.51M | -20.67M | -21.88M | -22.11M |
| Income Before Tax | -18.44M | 19.25M | -21.77M | -23.52M | -20.57M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -18.44M | 19.25M | -21.77M | -23.52M | -20.57M |
| Earnings from Discontinued Operations | -- | 885.00K | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -18.44M | 20.13M | -21.77M | -23.52M | -20.57M |
| EBIT | -9.08M | 12.51M | -20.67M | -21.88M | -22.11M |
| EBITDA | -8.78M | 12.85M | -20.32M | -21.50M | -21.72M |
| EPS Basic | -0.75 | 1.06 | -1.84 | -2.13 | -2.21 |
| Normalized Basic EPS | -0.39 | 0.65 | -1.15 | -1.33 | -1.39 |
| EPS Diluted | -0.75 | 1.05 | -1.84 | -2.13 | -2.21 |
| Normalized Diluted EPS | -0.39 | 0.64 | -1.15 | -1.33 | -1.39 |
| Average Basic Shares Outstanding | 24.63M | 19.05M | 11.82M | 11.05M | 9.29M |
| Average Diluted Shares Outstanding | 24.63M | 19.17M | 11.82M | 11.05M | 9.29M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |